Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

enstilar 50micrograms/g / 0.5 mg/g cutaneous foam

leo pharma - betamethasone dipropionate; calcipotriol monohydrate - cutaneous foam - 500microgram/1gram ; 50microgram/1gram

Enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam Ireland - English - HPRA (Health Products Regulatory Authority)

enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam

leo pharma a/s - calcipotriol; betamethasone - cutaneous foam - 50 mcg/g + 0.5 milligram(s)/gram - other antipsoriatics for topical use; calcipotriol, combinations

Enstilar 50 micrograms/0.5mg/g cutaneous foam. Malta - English - Medicines Authority

enstilar 50 micrograms/0.5mg/g cutaneous foam.

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - calcipotriol monohydrate, betamethasone dipropionate - cutaneous foam - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

ENSTILAR® CUTANEOUS FOAM 50mcgg + 0.5mgg Singapore - English - HSA (Health Sciences Authority)

enstilar® cutaneous foam 50mcgg + 0.5mgg

dksh singapore pte. ltd. - betamethasone dipropionate eqv. betamethasone; calcipotriol monohydrate eqv. calcipotriol - aerosol, foam - betamethasone dipropionate eqv. betamethasone 0.5mg/g; calcipotriol monohydrate eqv. calcipotriol 52.2mcg/g

ENSTILAR Israel - English - Ministry of Health

enstilar

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - cutaneous foam - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations - topical treatment of psoriasis vulgaris in adults

ENSTILAR Israel - English - Ministry of Health

enstilar

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - cutaneous foam - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations - topical treatment of psoriasis vulgaris in adults

Enstilar Cutaneous foam Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

enstilar cutaneous foam

leo pharma, denmark - betamethasone dipropionate,calcipotriol - cutaneous foam - 500,50 µg,

ENSTILAR calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can Australia - English - Department of Health (Therapeutic Goods Administration)

enstilar calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can

leo pharma pty ltd - calcipotriol, quantity: 20.5 microgram/g; betamethasone dipropionate, quantity: 264 microgram/g (equivalent: betamethasone, qty 205 microgram/g) - foam - excipient ingredients: polyoxypropylene-11 stearyl ether; liquid paraffin; dl-alpha-tocopherol; white soft paraffin; butane; methyl ether - enstilar is indicated for the topical treatment of psoriasis vulgaris in adults.

Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

enstilar 50micrograms/g / 0.5 mg/g cutaneous foam

pharmaram ltd - betamethasone dipropionate; calcipotriol monohydrate - cutaneous foam - 500microgram/1gram ; 50microgram/1gram

Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

enstilar 50micrograms/g / 0.5 mg/g cutaneous foam

de pharmaceuticals - betamethasone dipropionate; calcipotriol monohydrate - cutaneous foam - 500microgram/1gram ; 50microgram/1gram